Vanda Pharmaceuticals (VNDA) Tax Rate Growth (1y) (2011 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Vanda Pharmaceuticals | 379.35 Mn | 177.04 Mn | 48.56 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2,128.00 |
| Dec 31, 2025 | -29,659.00 |
| Sep 30, 2025 | 602.00 |
| Jun 30, 2025 | 398.00 |
| Mar 31, 2025 | 1,035.00 |
| Dec 31, 2024 | 6,890.00 |
| Sep 30, 2024 | -19,975.00 |
| Jun 30, 2024 | -2,435.00 |
| Mar 31, 2024 | -3,089.00 |
| Dec 31, 2023 | -7,258.00 |
| Sep 30, 2023 | 17,388.00 |
| Jun 30, 2023 | 1,078.00 |
| Mar 31, 2023 | 2,661.00 |
| Dec 31, 2022 | 1,083.00 |
| Sep 30, 2022 | 1,276.00 |
| Jun 30, 2022 | 825.00 |
| Mar 31, 2022 | -206.00 |
| Dec 31, 2021 | -709.00 |
| Sep 30, 2021 | -169.00 |
| Jun 30, 2021 | 177.00 |
| Mar 31, 2021 | -4,379.00 |
| Dec 31, 2020 | -223.00 |
| Sep 30, 2020 | 74,725.00 |
| Jun 30, 2020 | 2,149.00 |
| Mar 31, 2020 | 6,250.00 |
| Dec 31, 2019 | 2,771.00 |
| Sep 30, 2019 | -71,942.00 |
| Jun 30, 2019 | -176.00 |
| Mar 31, 2019 | -160.00 |
| Dec 31, 2018 | 437.00 |
| Sep 30, 2018 | 188.00 |
| Jun 30, 2018 | 237.00 |
| Mar 31, 2018 | 18.00 |
| Dec 31, 2011 | 20,407.00 |
| Sep 30, 2011 | 25,772.00 |
| Jun 30, 2011 | 664.00 |